You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mitoxantrone liposomes

Showing 1 - 25 of 265
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Treatment, Peripheral T-cell Lymphoma Trial in Beijing (liposomal mitoxantrone HCl, gemcitabine, dexamethasone, and cisplatin)

Recruiting
  • Treatment
  • Peripheral T-cell Lymphoma
  • liposomal mitoxantrone hydrochloride, gemcitabine, dexamethasone, and cisplatin
  • Beijing, China
  • +4 more
Jun 28, 2022

NK-T-Cell Lymphoma, Extranodal Trial (Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride

Not yet recruiting
  • NK-T-Cell Lymphoma, Extranodal
  • Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride and Dexamethasone (P-GEMD) regimen
  • (no location specified)
Mar 7, 2023

T Cell Lymphoma Trial (Cidapenem combined with azacitidine and mitoxantrone liposome (CAM) regimen)

Not yet recruiting
  • T Cell Lymphoma
  • Cidapenem combined with azacitidine and mitoxantrone liposome (CAM) regimen
  • (no location specified)
Mar 6, 2023

Lymphoma, Solid Tumors Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome)

Recruiting
  • Lymphoma, Solid Tumors
  • Mitoxantrone Hydrochloride Liposome
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 14, 2022

Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Cyclophosphamide)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • (no location specified)
Mar 9, 2023

Peripheral T Cell Lymphoma Trial in Zhejiang (Mitoxantrone liposome?Chidamide?Azacitidine)

Recruiting
  • Peripheral T Cell Lymphoma
  • Mitoxantrone liposome、Chidamide、Azacitidine
  • Zhejiang, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Aug 9, 2022

Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Isophosphamide)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • (no location specified)
Mar 23, 2023

Acute Leukemia Trial in Suzhou (mitoxantrone liposome, ATG)

Recruiting
  • Acute Leukemia
  • mitoxantrone liposome
  • ATG
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Feb 13, 2023

Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML) Trial in Guiyang (Mitoxantrone Hydrochloride liposome

Not yet recruiting
  • Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • Mitoxantrone Hydrochloride liposome injection
  • Cytarabine (LoDAC)
  • Guiyang, Guizhou, China
    The Affiliated Hospital of Guizhou Medical University
Oct 19, 2021

Healthy Volunteers Trial (Liposomal Amikacin for Inhalation)

Completed
  • Healthy Volunteers
  • Liposomal Amikacin for Inhalation
  • (no location specified)
Aug 11, 2023

Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)

Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Dec 1, 2023

Healthy Trial (763SIP8/MPLA-5 vaccine)

Not yet recruiting
  • Healthy
  • 763SIP8/MPLA-5 vaccine
  • (no location specified)
Mar 15, 2023

Esophageal Squamous Cell Carcinoma Trial (Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin
  • (no location specified)
Aug 17, 2023

Relapsing Multiple Sclerosis Trial in Beijing (Mitoxantrone Hydrochloride Liposome Injection)

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Mitoxantrone Hydrochloride Liposome Injection
  • Beijing, Beijing, China
    Xuanwu Hospital Capital Medical University
Aug 9, 2022

Neuromyelitis Optica Spectrum Disorder Trial (Mitoxantrone Hydrochloride Liposome Injection)

Not yet recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • Mitoxantrone Hydrochloride Liposome Injection
  • (no location specified)
Sep 20, 2022

DLBCL Trial in Jinan (Mitoxantrone Hydrochloride Liposome Injection)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • Jinan, Shandong, China
    Affiliated Cancer Hospital of Shandong First Medical University
May 16, 2023

Colorectal Cancer Trial in Shanghai (FOLFIRI+Bevacizumab)

Recruiting
  • Colorectal Cancer
  • Shanghai, Pudong, China
    Affiliated Cancer Hospital of Fudan University
Jul 24, 2023

Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Mitoxantrone hydrochloride liposome injection
  • +3 more
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 1, 2023

Relapsed/Refractory Multiple Myeloma Trial in Suzhou (Mitoxantrone HCl liposome/Dexamethasone/daratumumab)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Mitoxantrone hydrochloride liposome/Dexamethasone/daratumumab
  • Suzhou, Jiangsu, China
    Second Affiliated Hospital of Soochow University
May 4, 2023

Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Mitoxantrone hydrochloride liposome injection
  • +3 more
  • (no location specified)
May 29, 2023

T-lymphoblastic Lymphoma, Relapsed Disease, Refractory Lymphoma Trial in Shanghai (BCL2 Inhibitor plus IM2 regimen)

Recruiting
  • T-lymphoblastic Lymphoma
  • +5 more
  • BCL2 Inhibitor plus IM2 regimen
  • Shanghai, Shanghai, China
    Shanghai General hospital,Shanghai Jiao Tong University School o
Jan 10, 2023

Relapsed/Refractory Acute Myeloid Leukemia Trial in Worldwide (CPI-613 + High Dose Cytarabine and Mitoxantrone, High Dose

Terminated
  • Relapsed/Refractory Acute Myeloid Leukemia
  • CPI-613 + High Dose Cytarabine and Mitoxantrone
  • +3 more
  • Scottsdale, Arizona
  • +59 more
Jul 26, 2022

Autologous Stem Cell Transplantation, Conditioning Trial in Xi'an (modified BEAM, BEAM)

Not yet recruiting
  • Autologous Stem Cell Transplantation
  • Conditioning
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Apr 14, 2023

Prostate Cancer Trial in United States (bicalutamide, goserelin, mitoxantrone HCl)

Completed
Has Results
  • Prostate Cancer
  • Anchorage, Alaska
  • +233 more
Dec 5, 2022

Recurrent Metastatic Nasopharyngeal Carcinoma Trial (Mitoxantrone HCl liposome injection, Capecitabine)

Not yet recruiting
  • Recurrent Metastatic Nasopharyngeal Carcinoma
  • (no location specified)
Jan 29, 2023